Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
253
-
Total 13F shares, excl. options
-
62.8M
-
Shares change
-
+3M
-
Total reported value, excl. options
-
$5.04B
-
Value change
-
+$267M
-
Put/Call ratio
-
0.76
-
Number of buys
-
161
-
Number of sells
-
-94
-
Price
-
$80.25
Significant Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q1 2021
318 filings reported holding NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.8M shares
of 108M outstanding shares and own 58.25% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (9.61M shares), VANGUARD GROUP INC (5.58M shares), BlackRock Inc. (5.27M shares), Nikko Asset Management Americas, Inc. (4.84M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.81M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.32M shares), STATE STREET CORP (1.83M shares), ALLIANCEBERNSTEIN L.P. (1.76M shares), CHEVY CHASE TRUST HOLDINGS, INC. (1.32M shares), and Invesco Ltd. (1.23M shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.